ArticleClinical and molecular hepatology2025

Letter to the editor on "Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study".

Meng-Che Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.